ABSTRACT ) is an analogue of a natural antimicrobial peptide (AMP) previously isolated from the venom of wild bee. We examined its antimicrobial activity against three strains of Enterococcus faecalis while focusing on its susceptibility to proteolytic degradation by two known proteases-gelatinase (GelE) and serine protease (SprE)-which are secreted by these bacterial strains. We found that HYL-20 was primarily deamidated at its C-terminal which made the peptide susceptible to consecutive intramolecular cleavage by GelE. Further study utilising 1,10-phenanthroline, a specific GelE inhibitor and analogous peptide with D-Lys at its C-terminus (HYL-20k) revealed that the C-terminal deamidation of HYL-20 is attributed to not yet unidentified protease which also cleaves internal peptide bonds of AMPs. In contrast to published data, participation of SprE in the protective mechanism of E. faecalis against AMPs was not proved. The resistance of HYL-20k to C-terminal deamidation and subsequent intramolecular cleavage has resulted in increased antimicrobial activity against E. faecalis grown in planktonic and biofilm form when compared to HYL-20.
INTRODUCTION
Enterococcus faecalis is a common Gram-positive bacterium colonising the gastrointestinal tract and oral cavity of animals and humans (Macovei et al. 2009; Kavimandan 2016) . As an opportunistic pathogen, it causes infections of the urinary and female reproductive tracts and bloodstream, as well as endodontic infections, peritonitis, endocarditis, osteomyelitis, diabetic foot ulcers and meningitis (Coque et al. 1995; Zeng, Teng and Murray 2005; Kawalec et al. 2007; Lins et al. 2013; Frank et al. 2015) . It has become one of the leading causes of nosocomial infections.
These diseases are associated with E. faecalis's resistance to antibiotics and ability to form bacterial biofilms (Sandoe et al. 2006; Lins et al. 2013) . Among other virulence factors, two proteases produced by E. faecalis-gelatinase (GelE) EC 3.4.24.30. and serine protease (SprE)-have been described to play important roles in pathogenesis of various diseases, including endophthalmitis, peritonitis, endocarditis and orthopaedic implant infections (Singh et al. 1998; Sifri et al. 2002; Engelbert et al. 2004; Zeng, Teng and Murray 2005; Arciola et al. 2008; Thurlow et al. 2010) . GelE is a zinc metalloprotease II with endopeptidase activity isolated and partially characterised by Mäkinen et al. (1989) and Mäkinen and Mäkinen (1994) . SprE is an extracellular endopeptidase with amino acid sequence similarity to staphylococcal glutamyl endopeptidases, including V8 and GluSE (Kawalec et al. 2005) , but very little is known about its substrate specificity. Moreover, GelE and SprE have been shown to regulate bacterial autolysis and extracellular DNA release and thus contribute to E. faecalis biofilm formation (Hancock and Perego 2004; Thomas et al. 2008) .
Antimicrobial peptides (AMPs) have evolved as an important component of the host immunity system in almost all living organisms. AMPs provide efficient protection against various pathogens, including Gram-negative and Gram-positive bacteria, fungi and viruses (Zhang and Gallo 2016) . The overall positive charge and amphipathic secondary structure of their molecules allow AMPs to interact with negatively charged phospholipid bilayers of bacterial cell membranes, causing disruption via pore formation or detergent-like disintegration (Toke 2005; Nguyen, Haney and Vogel 2011; Wimley and Hristova 2011) . The significant advantage of AMPs resides in this mechanism of action, which is markedly different from that of conventional antibiotics and is assumed not to develop bacterial resistance. Due to these characteristics, they appear to be promising candidates for future application in the treatment of some infections. On the other hand, several reports have been published about various mechanisms by which bacteria protect themselves against various AMPs (for reviews, see Potempa and Pike 2009; Koprivnjak and Peschel 2011) . One of these mechanisms contributing to this resistance is the ability to degrade AMPs using various proteases which they release into the environment. Publications have shown, for example, that such common pathogenic bacteria as Staphylococcus aureus, Pseudomonas aeruginosa, E. faecalis, Proteus mirabilis and Streptococcus pyogenes produce proteases able to cleave human cathelicidin LL-37 (Schmidtchen et al. 2002; Sieprawska-Lupa et al. 2004) . GelE isolated from E. faecalis hydrolytically degraded AMP cecropin from Galleria mellonella haemolymph, and it also abolished bactericidal activity of fresh human serum. GelE and SprE also cleaved the α-chain of human complement factors C3 and C5, thereby resulting in altered neutrophil chemoattraction (Park et al. 2007; Thurlow et al. 2010) .
HYL-20 (GILSSLWKKLKKIIAK-NH 2 ) is an analogue of the natural hexadecapeptide named HYL, which was originally isolated from the venom of solitary bee Hylaeus signatus (Hymenoptera: Colletidae) (Nešuta et al. 2016) . Both peptides belong to the category of α-helical amphipathic AMPs. HYL-20 exhibited activities against several strains of pathogenic bacteria, including Staphylococci, P. aeruginosa and Candida albicans with minimum inhibitory concentrations (MICs) in the range <10 μM (Nešuta et al. 2016) . On the other hand, our preliminary results have shown that the activity of HYL-20 against E. faecalis was unexpectedly low while that of its all-D isomer (HYL-21) was substantially greater. These data indicated that the deterioration of HYL-20 activity apparently could consist in its degradation by proteases GelE and SprE secreted by E. faecalis.
In this work, we have focused primarily on understanding the role of these two proteases in HYL-20 degradation. For such study, we used 1,10-phenanthroline, a specific inhibitor of GelE (Bleiweis and Zimmerman 1964) , and an analogous peptide with C-terminal d-Lys (HYL-20k). Because of similarity in the substrate specificity of SprE to that of staphylococcal glutamyl endopeptidase V8 (Kawalec et al. 2005) , we also used model tetradecapeptide KRLFKELKFSLRKY-NH 2 (14-NH 2 ) as a substrate of the assumed SprE. Comparing the secondary structure of HYL-20 and HYL-20k, obtained by Nuclear Magnetic Resonance (NMR) spectroscopy, we tried to elucidate how or whether the studied peptides resist proteases secreted by E. faecalis. Using transmission electron microscopy and fluorescence confocal microscopy, we further studied the mechanism for the antimicrobial action of HYL-20 and HYL-20k against E. faecalis in both planktonic and biofilm-settled forms.
MATERIAL AND METHODS

Chemicals and bacterial strains
Fmoc-protected amino acids, Rink Amide MBHA resin and preloaded Lys(Boc)-Wang resin were purchased from IRIS Biotech GmbH, Marktredwitz, Germany. Vancomycin hydrochloride, LB broth, LB agar, endoproteinase Glu-C from Staphylococcus aureus V8 (V8 protease), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and 1,10-phenanthroline (PHN) were obtained from Sigma-Aldrich. All other reagents, solvents and HPLC-grade acetonitrile were of the highest purity available from commercial sources. Standard strains of Enterococcus faecalis 5483 (ATCC 29212) and 5530 (ATCC 51299) were purchased from the Czech National Collection of Type Cultures, the National Institute of Public Health, Prague, Czech Republic. E. faecalis (M) was obtained as a clinical isolate from University Hospital in Motol, Prague, Czech Republic.
Peptide synthesis
HYL-20, HYL-20k, HYL-21 and 14-NH 2 were synthesised manually according to the N α -Fmoc protocol on a Rink Amide MBHA resin in 5 mL polypropylene syringes with a Teflon filter on the bottom as described before (Nešuta et al. 2016 
Degradation of peptides
Bacteria were grown in brain-heart infusion (BHI) medium at 37
• C with continuous shaking for 3-5 h to mid-log phase and then pelleted by centrifugation at 7000 rpm for 10 min. HYL-20 and 14-NH 2 were digested by V8 protease in PBS in the ratio of substrate to enzyme 50:1 under the same conditions as described above.
To check viability of the bacteria during the experiments, aliquots of the mixture (100 μL) were taken at 0, 4 and 20 h; were then 10-fold serially diluted in sterile 0.9% saline; and were plated (100 μL) onto BHI agar in Petri dishes to count their colonies. Each peptide was tested in three independent experiments.
Mass spectrometry
Samples were analysed using an Agilent 1260 HPLC (Agilent Technologies) coupled to an ESI-TOF Agilent 6530 (Agilent Technologies) with Agilent Jet Stream Technology. Samples were separated on a Waters 1.7 μm, C18, 100 × 2.1 column at a flow rate of 0.3 mL min −1 . The concentration of mobile phase B (0.1% formic acid in acetonitrile) was gradually increased from 2% to 100% in mobile phase A (0.1% formic acid in water) over 10 min. The MS instrument was operated in a positive ion mode with a voltage of + 3.00 kV applied to the capillary. The temperature, flow rate of nitrogen drying gas, pressure of nitrogen nebulising gas, temperature and flow rate of sheath gas were set at 325 • C, 10 L min −1 , 40 psi, 390
• C and 11 L min −1 , respectively.
Antibacterial activity determination
Bacteria were grown in BHI medium at 37
• C with continuous shaking for 3-5 h to mid-log phase. Afterwards, this bacterial suspension was diluted in fresh BHI medium to a final concentration of ∼5 × 10 5 CFU mL −1 and 0.1 mL of that inoculum was added to the wells containing 0.1 mL of tested compounds in different concentrations previously prepared from 1 or 10 mmol L −1 stock solutions by 2-fold serial dilution in BHI medium (final volume in the well was 200 μL). Fresh medium with bacteria was only used as growth control. Final concentrations of tested compounds in the wells after addition of bacterial suspension ranged from 0.1 to 1024 μmol L −1 . The plates were incubated at 37
• C for 20 h while being continuously shaken in a Bioscreen C instrument (Oy Growth Curves AB Ltd., Helsinki, Finland). The absorbance was measured at 540 nm every 15 min. MIC values for each compound were determined from the growth curves plotted from the data obtained. Afterwards, 10 μL aliquots were transferred from the wells with no visible growth onto BHI agar plates and incubated overnight in order to determine minimum bactericidal concentration (MBC). Each peptide and vancomycin was tested at least three times in duplicates.
Antibiofilm activity determination
Bacteria grown overnight in BHI medium were diluted in fresh BHI medium (supplemented with 1% of glucose) to a concentration of ∼10 7 CFU mL −1 . Then 0.1 mL of this suspension was added to a 96-well flat bottom polystyrene microtiter plate. The plate was sealed with breathable film and incubated at 37
• C with continuous shaking. After 2 h, supernatant with non-adhered bacteria was removed and the wells with adhered bacteria were gently rinsed twice with 0.3 mL of sterile saline (0.9% NaCl) and then filled with 0.1 mL of fresh BHI medium (supplemented with 1% of glucose). The plate was continuously shaken at 37
• C for 24 h in order to grow bacterial biofilms in the wells. Afterwards, the medium was removed and the biofilms were rinsed gently three times with 0.3 mL of sterile saline and covered with fresh BHI medium (0.1 mL) containing tested concentrations of peptides or vancomycin (1 to 1024 μmol L −1 ) prepared by 2-fold serial dilutions. The wells containing biofilm covered with BHI medium served as a control and the wells with medium alone without pregrown biofilm served as a blank control. The plate was incubated at 37
• C for another 20 h, after which the cultivation medium was removed and each well was gently rinsed twice with 0.3 mL of sterile saline. Fresh BHI medium (0.1 mL) and 10 μL of MTT from a stock solution (5 mg mL −1 in sterile MiliQ H 2 O) were added to each well. After 40 min of incubation at 37
• C, the medium with MTT was removed and formed formazan crystals were solubilised in 0.1 mL of dimethyl sulfoxide. Absorbance at 540 nm was measured in each well on a Tecan infinite M200 PRO reader (Tecan Austria GmbH). Residual metabolic activity of bacteria in biofilm (RMAB) was calculated from as follows:
where A bl , A c and A t , are absorbance of blank, control biofilm and compound-treated biofilm, respectively. For each peptide and vancomycin, the percentage of RMAB was plotted against the log 10 of their concentrations and the biofilm eradication concentration BEC 50 was interpolated as the concentration of the substance causing 50% decrease in metabolic activity of bacteria in biofilm. All compounds were tested in at least three independent experiments.
Extraction of bacteria from the grown biofilm
Biofilms 24 h old grown in a 96-well microtiter plate were rinsed three times with 0.3 mL sterile saline and poured with 0.2 mL of sterile saline. The plate was closed with sterile sealing film and sonicated for 3 min. Bacteria released from the disrupted biofilm were collected in a sterile 15 mL Falcon tube, centrifuged and washed with sterile saline. Pelleted bacteria were resuspended in fresh BHI medium and used for MIC and MBC determination assay similarly as described above.
Statistical analysis
The results from antimicrobial and antibiofilm activity determination were compared using either t-test or one-way analysis of variance. Differences were considered statistically significant at the P < 0.05.
Laser scanning confocal microscopy
An overnight culture of E. faecalis (M) diluted in fresh BHI medium (supplemented with 1% glucose) to ∼10 7 CFU mL
was incubated in a four-chamber glass bottom dish in order to prepare model biofilms. After 2 h, chambers were rinsed twice with sterile saline, fresh BHI medium (supplemented with 1% glucose) was added and the dish was incubated for 48 h without shaking. After 24 h, culture supernatant in the dish was replaced with fresh medium. Grown biofilms were gently rinsed three times with sterile saline, covered with 0.2 mL of fresh BHI medium containing HYL-20, HYL-20k or vancomycin in a concentration of 128 μmol L −1 and incubated for another 20 h. Biofilms incubated with BHI medium only served as a control. Afterwards, supernatants were discharged and the biofilms were gently washed twice with sterile saline. Biofilms were stained with 0.2 mL of FilmTracer LIVE/DEAD R Biofilm Viability Kit (Molecular Probes, Thermo Fisher Scientific) according to the manufacturer's staining protocol for 25 min in darkness. Stained biofilms were gently rinsed and covered with 0.2 mL of sterile saline. Laser scanning confocal microscopy imaging was performed on an LSM 780 inverted confocal microscope (Zeiss, Jena, Germany) equipped with a 40×/1.20 W objective lens in a 'z-stack' mode with slice thickness interval of 0.7 μm. Syto-9 (LIVE stain) and propidium iodide (DEAD stain) were excited at 488 and 561 nm, respectively. Emission was collected in the following wavelength ranges: 499-543 nm (Syto-9) and 613-703 nm (propidium iodide). Three-dimensional reconstructions were performed using Zen software (Zeiss Instruments).
NMR spectroscopy and structural calculations
NMR spectra were acquired from 0.66 mL samples of 5 mmo L −1 HYL-20 and HYL-20k in aqueous solution of 10% D 2 O/90% H 2 O (pH 2.94 and 3.21, respectively) and in the presence of 30% deuterated trifluoroethanol (TFE-d 2 ). All NMR data were collected at 25
• C on a 600 MHz Bruker AVANCE III HD spectrometer equipped with a triple-resonance ( 15 N/ 13 C/ 1 H) cryoprobe. We obtained complete sequence-specific resonance assignments using a combination of 2D homonuclear experiments and carried out structural calculations using the NMR-based distance and dihedral angle restraints. Tables S2-S5 (Supporting Information) . For further details of NMR measurement and structure calculations, see our previous article (Nešuta et al. 2016) . The 30 structures with the lowest total energy were analysed using the PyMOL. The structures and assigned chemical shifts for HYL-20 and HYL-20k were deposited in PDB database under accession codes 5MMK and 5MML, and BMRB database under accession codes 34074 and 34075.
Transmission electron microscopy
Overnight culture of E. faecalis (M) in BHI medium was 10× diluted in fresh medium and incubated for another 1 h. This suspension containing ∼10 9 CFU mL −1 (0.85 mL) was mixed with the solution of peptide (HYL-20 or HYL-20k) in sterile saline (0.15 mL) so that the final concentration of each peptide was 30 μmol L −1 or 150 μmol L −1 . The bacterial suspension mixed with sterile saline only (0.15 mL) served as a blank control. The mixtures were incubated at 37
• C for 1 h, and then the suspensions of bacteria were centrifuged and washed twice with sterile saline. Subsequently, the bacterial cells were adsorbed on Parlodioncarbon-coated copper grids for 5-10 min. After a short washing, the samples were negatively stained using 0.25% phosphotungstic acid (pH 7.3) with 0.01% bovine serum albumin in H 2 O for 30-40 s and then air-dried.
The procedure to obtain ultrathin sections of the E. faecalis cells was as follows: the bacterial cells were centrifuged and resuspended in 20% dextran in PBS. This suspension was transferred on appropriate copper carrier and rapidly frozen in a Leica EM PACT2 High Pressure Freezer. Then the samples were transferred to a Leica EM AFS freeze-substitution apparatus. Freeze substitution was performed in anhydrous acetone containing 2% uranyl acetate and 0.5% glutaraldehyde. The samples were kept at -90
• C, -70
• C and -50
• C for 8 h at each temperature. Then the samples were washed three times with anhydrous acetone and gradually infiltrated with Lowicryl HM20 and polymerised by UV light. Ultrathin sections were cut at 70 nm, mounted onto copper grids, and stained with uranyl acetate and lead citrate. All the specimens were then examined using a JEOL JEM 1011 transmission electron microscope operating at 80 kV. Figure 1 shows the time course of HYL-20 degradation by proteases secreted by E. faecalis (M) as followed by RP-HPLC. The fragmentation of HYL-20 proceeded via C-terminal deamidation manifested after 20 min by the appearance of the peak at shorter retention time (HYL-20-OH) accompanied by a decrease in the peak area of amidated peptide (HYL-20). The deamidated hexadecapeptide (HYL-20-OH) was further cleaved at the Lys12-Ile13 and subsequently the Lys9-Leu10 peptide bonds, as manifested by the appearance of fragment F1 (Fig. 1C and D) and F2 (Fig. 1E) , respectively. After 4 h, the degradation resulted in the disappearance of HYL-20 as well as of HYL-20-OH. In the extended time period (Fig. 1F) , the cleavage of F1 and F2 fragments continued under the formation of shorter peptide fragments F3-F7 and tryptophan. All those fragments were analysed by MS, which confirmed their identities as summarised in Table 1 . The cleavage pattern of HYL-20 was identical for all three strains of E. faecalis. Incubation of E. faecalis with synthetic HYL-20-OH resulted in formation of the same fragments as those originated from HYL-20 (not shown).
RESULTS
Degradation of HYL-20 and HYL-20k by Enterococcus faecalis proteases
Assuming the C-terminal deamidation to be the initial step of HYL-20 degradation, we designed and prepared analogous HYL20k containing C-terminal Lys residue in d-configuration in order to discontinue this deamidation step. Time courses of HYL-20, HYL-20k and HYL-21 (all-d analogue of HYL-20) degradation by proteases secreted by three different strains of E. faecalis show (Fig. 2) that HYL-21 resisted their activity as expected. That was in contrast to HYL-20, which was cleaved. On the other hand, HYL-20k also resisted these proteases. This indicated that the cleavage of HYL-20 into smaller fragments by proteases released from E. faecalis is stipulated by the initial C-terminal deamidation of the peptide.
We recently structurally characterised HYL-20 using NMR spectroscopy in water as well as in 30% TFE-d 2 (Nešuta et al. 2016) . In this work, we obtained NMR data for HYL-20k under same conditions in order to evaluate the impact of its C-terminal Lys configuration. Proton NMR parameters are summarised in Tables S2-S5 (Supporting Information). The observation of only intraresidual and sequential NOEs protons shows that both peptides adopt random coil conformation in water. Certain propensity towards helical form can be indicated by rather lower values of J(NH,Hα) couplings and mostly low negative values of Table 1 ) visible as peaks on the chromatograms contain Trp, which contributes substantially to their absorption at 220 nm. The other Trp-free fragments which were products of HYL-20 degradation were outside of the detection limit. Table S1 ). Also the CSI values -0.01 and + 0.03 ppm for Ala15 and d-Lys16 in HYL-20k are out of the helical range. This could be a result of slightly larger flexibility of HYL-20k resulting from the absence of the hydrogen bond between the backbone amide group of Lys16 and carbonyl of Ile13 stabilising the C-terminal α-helical conformation (Nešuta et al. 2016) . However, the highly overlapping NMR spectra suggest that HYL-20k adopts a similar α-helical conformation in 30% TFE to that observed for HYL-20 (Nešuta et al. 2016) . Occasionally, we detected traces of F1 fragment during the assay with HYL-20k (data not shown), thus suggesting that a negligible part of the peptide may be cleaved independently of the C-terminal deamidation. 
Degradation of HYL-20 in the presence of a specific GelE inhibitor
To distinguish between the contribution of GelE and putative SprE to peptide degradation, we used for this experiment an inhibitor of GelE, PHN. When HYL-20 was incubated with E. faecalis in the presence of PHN, then HYL-20 was completely deamidated at its C-terminus after 4 h (Fig. 3B) . The product of this deamidation, HYL-20-OH, remained present and uncleaved in the mixture through the end of the incubation (Fig. 3C ). This indicates that the deamidation of the peptide was probably caused by SprE or by another protease and that the cleavage of internal peptide bonds can be attributed to GelE. That is valid for all three bacterial strains. Only traces corresponding to fragment F1 were detected occasionally after 20 h of incubation (data not shown).
Degradation of 14-NH 2 by V8 protease and Enterococcus faecalis proteases
We used 14-NH 2 , a peptide with sequence KRLFKELKFSLRKY-NH 2 , as a suitable substrate for putative SprE inasmuch as this protease is supposed to have similar substrate specificity as does the V8 protease (Kawalec et al. 2005) . As expected, the peptide was cleaved by commercial V8 protease only at the Glu6-Leu7 peptide bond in two fragments. These were isolated and clearly identified by MS as KRLFKE (Mr = 819.50) and LKFSLRKY-NH 2 (Mr = 1052.66). In the parallel experiment, HYL-20 was neither cleaved at any peptide bond nor deamidated by V8 protease. On the other hand, the degradation of 14-NH 2 by E. faecalissecreted proteases and proceeding via C-terminal deamidation manifested itself after 1 h by appearance of the adjacent peak at longer retention time (14-OH) that was accompanied by a decrease of the peak area of 14-NH 2 . The 14-OH was further (after 4 h) preferentially cleaved at the Phe9-Ser10 and Leu7-Lys8 peptide bonds, as confirmed by the MS identification of isolated peptide fragments labelled in the RP-HPLC profile respectively as F7, F1, and F5, F6 (Fig. 4A) . Further identified fragments which appeared after 24 h of digestion also originated from the cleavage at peptide bonds with hydrophobic Phe and Leu in the P1 position and hydrophilic residues in the P1 position (Fig. 4A) . The degradation of 14-NH 2 by E. faecalis-secreted proteases in the presence of PHN proceeded similarly in the parallel exper- iment via C-terminal deamidation to formation of the deamidated peptide 14-OH and the peptide fragments corresponding to the cleavage at the Phe9-Ser10 and Leu7-Lys8 peptide bonds (Fig. 4B ). Contrary to our expectation, we did not identify in the mixture containing PHN any peptide fragments which would correspond to cleavage of the 14-NH 2 at the Glu6-Leu7 peptide bond. Cleavage at this peptide bond was initially anticipated based on the published data describing the specificity of SprE for the Glu-X peptide bond (Kawalec et al. 2005) . Nevertheless, we identified fragment F2 in the digestion mixture without PHN, and this corresponds to that cleavage.
Antibacterial activity of peptides against planktonic and biofilm-settled Enterococcus faecalis
Antibacterial activities expressed as MIC and MBC and antibiofilm activities expressed as BEC 50 of tested peptides against all three strains of E. faecalis are shown in Tables 2 and 3 . The similarity of MIC and MBC values (P > 0.05) revealed that all peptides tested were bactericidal against planktonic cells, whereas vancomycin showed only bacteriostatic activity. HYL-20 showed 2.5-to 5-fold lower activity than its all-d isomer HYL-21 against all three strains of E. faecalis (P < 0.05). HYL-20k was twice more active than HYL-20 (P < 0.05) but still less active than HYL-21 (Table 2) . However, the differences between activities of HYL-20k and HYL-21 were not statistically significant (P > 0.05). All peptides tested showed antibiofilm activity in concentration ranges comparable to those of their antibacterial activities (Table 3) . VAN-vancomycin. Nevertheless, difference between BEC 50 of HYL-20 and either HYL-21 or HYL-20k was statistically significant (P < 0.05) only when tested against biofilm formed by E. faecalis 5530. In anticipation of increased resilience of bacteria living in the biofilm against antimicrobial agents, we extracted them from the matured biofilm and used them for common tests of antimicrobial activity determination. However, the MIC and MBC values of the studied peptides, as well as of vancomycin, for these biofilm-extracted bacteria were comparable to those for normal planktonic bacteria (Table 2) . Interestingly, vancomycin was not able to kill bacteria settled in biofilm whereas it was equally active in terms of MIC values as were peptides against both planktonic and biofilm-extracted bacterial cells.
Antibiofilm activity followed by laser scanning confocal microscopy
Enterococcus faecalis (M) biofilms were stained with FilmTracer LIVE/DEAD Biofilm Viability Kit containing two fluorescent nucleic acid stains-SYTO R 9 and propidium iodide. Under the microscope, the living bacteria appeared green (SYTO R 9) while the dead bacteria red (propidium iodide). Three-dimensional reconstructions from confocal fluorescent micrograms of 48-h biofilms treated for 20 h with 128 μM vancomycin (Fig. 5B) showed that, as in the control biofilm (Fig. 5A) , the majority of bacteria were alive and dead bacteria were rare and located only in the basal layer of biofilm structure. On the other hand, the biofilm treated with the same concentration of HYL-20 or HYL-20k contained higher quantity of dead bacterial cells and these bacteria could be seen within all Scale bars: 100-500 nm.
levels of the biofilm mass ( Fig. 5C and D, respectively) indicating bactericidal effect of these peptides independent on bacterial location.
Transmission electron microscopy
Morphological changes in E. faecalis treated with HYL-20 or HYL20k were observed by transmission electron microscopy with negative staining. Untreated control bacteria displayed ovalshaped proliferating cells exhibiting an electron-dense character and well-preserved envelope structures (Fig. 6A) . The bacteria treated with peptides became electron transparent, and many of them revealed serious damage characterised by massive leakage of their inner content exclusively from a single huge hole in the cell, thereby giving them a comet-like appearance ( Fig. 6B and C) . We assume this to be the consequence of peptides' action at the bacterial septum. This phenomenon can be explained based upon published data (Tran et al. 2013) showing that the negatively charged phospholipids phosphatidylglycerol and cardiolipin constitute the main phospholipids of the E. faecalis membrane and that the cardiolipin-enriched domains are localised mostly at the bacterial septum and poles. Thus, positively charged HYL molecules preferentially bind to the cell membrane at these domains enriched in negatively charged cardiolipin and accumulate there. Their interaction with the membrane produces alterations and finally damage to its structure, thereby leading to the leakage of bacterial content and cell death ( Fig. 6B and C) . These morphological changes were observed for both peptides, independent of their concentrations used in the experiment. Electron micrographs of ultrathin sections of untreated bacteria showed oval cells with intact cell wall and clearly visible, well-preserved membrane (Fig. 6D) . Sections of treated bacteria cells revealed disassembling of their envelopes prevalently at the poles of the cells, with remains of their cell membrane still attached to the surface of the cell body flanks (Fig 6E) . Others show leakage of the cell content, and some exhibit shrunken residues of the cell content still surrounded by the remains of damaged cell membrane and wall (Fig. 6F) .
DISCUSSION
HYL-20 prepared in our laboratory as an analogue of the natural α-helical peptide HYL possesses potent antimicrobial activity against Gram-positive and Gram-negative pathogenic bacteria (Nešuta et al. 2016) but not against Enterococcus faecalis. Here, we show that the reason for it is apparently due to degradation of HYL-20 by the previously identified extracellular protease GelE (Mäkinen et al. 1989; Mäkinen and Mäkinen 1994; Kawalec et al. 2005) and another not yet identified protease secreted by E. faecalis as part of the mechanism protecting the bacterium against AMPs. GelE is a bacterial metalloendopeptidase that cleaves peptide substrates primarily at peptide bonds involving hydrophobic amino acid residues. The cleavage of HYL-20 preferentially at internal Lys12-Ile13 and Lys9-Leu10 peptide bonds is in agreement with previously published data regarding the substrate specificity of GelE. Those literature data (Mäkinen et al. 1989; Mäkinen and Mäkinen 1994) show that GelE specifically hydrolysed peptide bonds with P1 position occupied by Leu, Ile, Phe and Trp, whereas the P1 position was less specific and was also occupied by hydrophilic residues. We found that the initial step of HYL-20 degradation is manifested by pronounced deamidation of C-terminal Lys-NH 2 residue followed by consequent cleavage of internal peptide bonds. We also observed the same cleavage pattern of internal peptide bonds in the case of non-amidated HYL-20-OH. Because none of the literature data provide any information about C-terminal deamidation of peptides catalysed by GelE, we were led to speculate that the HYL-20 deamidation might be caused by SprE or by another putative protease. That hypothesis was strongly supported by the results of the experiment demonstrating unequivocal C-terminal deamidation in the presence of GelE inhibitor PHN. Based on these results, we also postulate that the initial C-terminal deamidation of HYL-20 is the prerequisite for consequent cleavage of internal peptide by GelE.
On the other hand, SprE was reported to be a close homologue of V8 protease from Staphylococcus aureus given their high degree of sequence similarity (Kawalec et al. 2005) . V8 protease and SprE cleave specifically Glu-Xaa peptide bonds but not AspXaa bonds (Kawalec et al. 2005) . However, no information about C-terminal deamidation of peptides by either SprE or V8 protease can be found in the literature. Therefore, we subjected HYL-20 to digestion by commercial V8 protease in order to see whether any cleavage of this peptide would occur. We observed neither deamidation of HYL-20 nor cleavage of its internal peptide bonds. This observation raised the following questions: (1) Was SprE secreted at all by E. faecalis into the environment under the experimental conditions used, and (2) was the deamidation of HYL-20 caused by another unknown protease of E. faecalis? To answer the first question, we used a C-terminally amidated tetradecapeptide (14-NH 2 ) containing in its sequence a Glu6-Leu7 peptide bond and incubated it with E. faecalis to see whether the peptide is cleaved at this, for SprE specific, peptide bond. Surprisingly, we observed evident deamidation of Cterminal Tyr-NH 2 accompanied by cleavage of internal peptide bond preferentially at peptide bonds occupied at the P1 position by hydrophobic Phe or Leu residues and at the P1 position occupied by hydrophilic Ser or Lys residues. The anticipated cleavage at the Glu6-Leu7 peptide bond was insignificant. In the control experiment, incubation of the 14-NH 2 with V8 protease resulted explicitly in two peptide fragments originated from cleavage of the peptide at the Glu6-Leu7 peptide bond but no deamidation of its C-terminal Tyr-NH 2 was observed. In this context, we may consider a new, as yet unidentified protease which E. faecalis secrets into the environment to be a part of its protective mechanism against AMPs.
To further elucidate the mechanism by which E. faecalis resists HYL-20, we used its analogue with C-terminal Lys-NH 2 in dconfiguration . Surprisingly, HYL-20k was resistant not only to C-terminal deamidation but also to further subsequent cleavage of internal peptide bonds as occurred in HYL-20. NMR data obtained in 30% TFE suggested that the C-terminus of HYL20k has a different conformation than does HYL-20 due to absence of the involvement of d-Lys-NH 2 in the hydrogen-bonding network.
Moreover, the changes in the HYL-20k α-helical structure result in its faster elution from C-18 column during RP-HPLC as compared to HYL-20. This reflects different interactions of these two peptides with the stationary phase of the C-18 column. As already reported (Monincová et al. 2010) , the interactions of α-helical AMPs with the C-18 phase of the column are similar to those between AMPs and biological membranes. Accordingly, the structural differences between HYL-20, HYL-20k, HYL-21 and HYL-20-OH should result in varying antimicrobial activity among them. Particularly in this work, the C-terminal amidation of HYL-20 enhances the net positive charge and contributes to stabilisation of its α-helical structure (Sforça et al. 2004; Mura et al. 2016) , thus reflecting its higher antimicrobial activity in comparison with HYL-20-OH.
Nevertheless, it is evident that the structural features of the studied peptides have no prevalent effect on antimicrobial activity against E. faecalis. The efficacy of these peptides depends predominantly on their stability in the face of the proteolytic activity produced by E. faecalis. The order of antimicrobial activity (Table 1 ) against E. faecalis being HYL-21 > HYL-20k > HYL-20 > HYL-20-OH correlates well with the propensity of peptides to resist its proteolytic activity. This is further supported by observation that the degradation fragment F1 had no activity against any of the three strains. Degradation of HYL-20 and HYL-20-OH clearly explains their low activity against this bacterium, while the all-d analogue (HYL-21) with the highest activity and HYL20k were resistant to it. The lower activity of HYL-20k as compared to HYL-21 reflects distortion of its α-helical structure at the C-terminus.
We also demonstrated here that the studied peptides exhibit significantly higher efficiency against E. faecalis cells in the biofilm than does vancomycin (determination of residual metabolic activity of bacterial cells using MTT staining), despite its greater activity against planktonic cells. This was highly supported by visualisation of killed bacterial cells inside the biofilms using confocal fluorescent microscopy. Moreover, we observed only a bacteriostatic effect of vancomycin against E. faecalis, whereas the effect of HYLs was bactericidal in all cases. This finding is in accordance with the literature stating that vancomycin is considered to be bacteriostatic against enterococci in vitro (Anderson et al. 2012) .
We previously described that HYL and its analogues cause membrane damage to Gram-negative bacteria in a concentration-dependent manner (Nešuta et al. 2016) . As is clear from observing the action of the studied peptides on E. faecalis by electron microscopy, their killing mechanism in this case also resides in rapid mechanical breakage of the bacterial cell membrane independent of bacterial metabolic activity or growth status. On the other hand, vancomycin acts on Gram-positive bacteria by inhibiting their cell wall synthesis (Anderson et al. 2012) and the bacteria are able to develop resistance against it.
CONCLUSIONS
In the present work, we primarily focused on studying the proteolytic activity produced by Enterococcus faecalis which protects it against the killing effect of AMPs. The literature data show that the main constituents of E. faecalis proteolytic activity are represented by GelE and SprE. Based on our presented results using several AMPs, we suggest that this protective mechanism is primarily composed of GelE and another unidentified protease. This protease, which cleaves internal peptide bonds of peptides preferentially at hydrophobic residues, also deamidates their Cterminal amides. The deamidation step seems to be the prerequisite for consequent cleavage of internal peptide bonds. The identification of this protease will be a subject of our further study. Surprisingly, we did not prove participation of SprE in the protective mechanism of E. faecalis against AMPs. Moreover, we have shown that the modest modification of AMP by introducing a single d-amino acid residue at the C-terminal may result in a potent peptide analogue resilient to that protective mechanism of E. faecalis.
